INFLAMEX Trademark

Trademark Overview

On Friday, May 5, 2023, a trademark application was filed for INFLAMEX with the United States Patent and Trademark Office. The USPTO has given the INFLAMEX trademark a serial number of 97922580. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, September 9, 2024. This trademark is owned by PURETEK CORPORATION. The INFLAMEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
inflamex

General Information

Serial Number97922580
Word MarkINFLAMEX
Filing DateFriday, May 5, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 11, 2023
Primary Code005
First Use Anywhere DateSaturday, June 1, 2024
First Use In Commerce DateSaturday, June 1, 2024

Trademark Owner History

Party NamePURETEK CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Addresspanorama city, CA 91402

Trademark Events

Event DateEvent Description
Tuesday, May 9, 2023NEW APPLICATION ENTERED
Thursday, May 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 5, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, October 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, November 20, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, November 20, 2023PETITION TO REVIVE-GRANTED
Monday, November 20, 2023NOTICE OF REVIVAL - E-MAILED
Monday, November 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, April 10, 2024ASSIGNED TO LIE
Wednesday, April 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 2, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, July 10, 2024USE AMENDMENT ACCEPTED
Tuesday, July 2, 2024USE AMENDMENT FILED
Tuesday, July 2, 2024AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, July 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 9, 2024FINAL REFUSAL E-MAILED
Monday, September 9, 2024FINAL REFUSAL WRITTEN
Monday, September 9, 2024NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

inflamex disorders inflammation pain sepsis alopecia cognitive obesity blood substances preparations